APA

Foley J. E., Jung U., Miera A., Borenstein T., Mariotti J., Eckhaus M., Bierer B. E. & Fowler D. H. (20051129). Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism. : Journal of immunology (Baltimore, Md. : 1950).

Chicago

Foley Jason E, Jung Unsu, Miera Angel, Borenstein Todd, Mariotti Jacopo, Eckhaus Michael, Bierer Barbara E and Fowler Daniel H. 20051129. Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism. : Journal of immunology (Baltimore, Md. : 1950).

Harvard

Foley J. E., Jung U., Miera A., Borenstein T., Mariotti J., Eckhaus M., Bierer B. E. and Fowler D. H. (20051129). Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism. : Journal of immunology (Baltimore, Md. : 1950).

MLA

Foley Jason E, Jung Unsu, Miera Angel, Borenstein Todd, Mariotti Jacopo, Eckhaus Michael, Bierer Barbara E and Fowler Daniel H. Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism. : Journal of immunology (Baltimore, Md. : 1950). 20051129.